PXS Stock Chart & Stats
€0.09
€0.01(5.22%)
At close: 4:00 PM EST
€0.09
€0.01(5.22%)
Day’s Range― - ―
52-Week Range€0.06 - €0.21
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€147.41M
Enterprise Value€722.97
Total Cash (Recent Filing)€30.86M
Total Debt (Recent Filing)€464.29M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,655,305,400
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)1.90
Price to Sales (P/S)0.17
P/FCF Ratio-26.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.10Price Target Upside15.45% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)€2.26B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue Via Consumables & ServicesThe mix of upfront equipment sales plus consumables and contracted service/support creates recurring revenue streams from an installed base. This structural business model increases revenue predictability, supports aftermarket margins, and anchors long-term customer relationships.
Manageable Leverage And Reasonable Equity CushionA debt-to-equity near 1.0 with a ~26% equity ratio indicates moderate leverage that preserves financial flexibility. Manageable gearing reduces near-term refinancing risk and gives the company room to fund working capital or targeted investments without immediate balance-sheet stress.
Operational Margin ImprovementsTraction in EBIT/EBITDA margins signals operational efficiency gains and tighter cost controls. If sustained, these structural improvements support profitability leverage on future revenue recovery and enhance cash generation potential versus prior periods.
Bears Say
Sharp Revenue DeclineA steep revenue drop reduces scale economics and weakens bargaining power with suppliers and customers. Sustained top-line contraction hampers ability to cover fixed costs, constrains reinvestment in service capacity, and undermines medium-term cash generation.
Thin Gross And Net MarginsVery low gross and net margins leave little buffer against cost inflation, supplier pricing pressure, or competitive discounting. Margin compression materially limits retained earnings for investment and makes profitability highly sensitive to small revenue or cost shifts.
Negative Operating Cash Flow And Weak Cash ConversionNegative operating cash flow indicates difficulties converting accounting profits to cash, increasing reliance on external funding or working capital. Volatile FCF growth from a negative base raises sustainability concerns for ongoing service support and inventory-funded distribution activities.
Paragon Care Limited News
PXS FAQ
What was Paragon Care Limited’s price range in the past 12 months?
Paragon Care Limited lowest stock price was €0.06 and its highest was €0.21 in the past 12 months.
What is Paragon Care Limited’s market cap?
Paragon Care Limited’s market cap is €147.41M.
When is Paragon Care Limited’s upcoming earnings report date?
Paragon Care Limited’s upcoming earnings report date is Aug 27, 2026 which is in 36 days.
How were Paragon Care Limited’s earnings last quarter?
Paragon Care Limited released its earnings results on Feb 24, 2026. The company reported -€0.792 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Paragon Care Limited overvalued?
According to Wall Street analysts Paragon Care Limited’s price is currently Undervalued.
Does Paragon Care Limited pay dividends?
Paragon Care Limited does not currently pay dividends.
What is Paragon Care Limited’s EPS estimate?
Paragon Care Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Paragon Care Limited have?
Paragon Care Limited has 1,655,305,400 shares outstanding.
What happened to Paragon Care Limited’s price movement after its last earnings report?
Paragon Care Limited reported an EPS of -€0.792 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -16.522%.
Which hedge fund is a major shareholder of Paragon Care Limited?
Currently, no hedge funds are holding shares in DE:PXS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Paragon Care Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€0.10 (15.45% Upside)
€0.10 (15.45% Upside)
Blogger Sentiment
Bullish
DE:PXS Sentiment 100%
Sector Average 66%
Sector Average 66%
Insider Transactions
Bought Shares
Worth €16.5K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.09%
Trailing 12-Months
Company Description
Paragon Care Limited
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems. In addition, the company offers aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; natural, traditional, and complementary health products and services; critical care and dental solutions; urology solutions, such as shockwave therapy, lasers, and accessories for infection control; medical products and consumables; and orthopaedics solutions, including hip and knee arthroplasty, upper and lower extremity, sports medicine, reverse shoulder replacement, and powered surgical tools. Further, it offers medical equipment repair, maintenance, and support services; technology and communication solutions, such as telephony, nurse call, access control, cctv, cordless, and Wi-Fi; supplies medical equipment to veterans, war widows, and families; and veterinary products. Additionally, it is involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. The company is based in Mount Waverley, Australia.
PXS Stock 12 Month Forecast
Average Price Target
€0.10
▲(15.45% Upside)
Technical Analysis
Sigma Healthcare Ltd
―
Polynovo
―
Compumedics Limited
―
Epsilon Healthcare Limited
―
Trajan Group Holdings Ltd
―